Lianhua-Qingwen Displays Antiviral and Anti-Inflammatory Activity and Synergistic Effects with Oseltamivir against Influenza B Virus Infection in the Mouse Model

<div>The pathological change of B0215‐infected mice lungs after treatment with LQ. (a) Uninfected. (b) Placebo. (c) Treated with 75 mg/kg/day of ribavirin. (d–f) Treated with 100, 200, and 400 mg/kg/day of LQ, respectively (100x).</div>

Evidence-Based Complementary and Alternative Medicine

fig5

Figure 5

Figure 5: Lianhua-Qingwen Displays Antiviral and Anti-Inflammatory Activity and Synergistic Effects with Oseltamivir against Influenza B Virus Infection in the Mouse Model 

Figure 5 | Lianhua-Qingwen Displays Antiviral and Anti-Inflammatory Activity and Synergistic Effects with Oseltamivir against Influenza B Virus Infection in the Mouse Model 